Rafferty Asset Management
EXAS

Rafferty Asset Management’s Exact Sciences EXAS Stock Holding History

Rafferty Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-57,455
Closed -$5.84M – 1092
2025
Q4 		$5.84M Sell
57,455
-89,513
-61% -$7.19M 0.02% 390
2025
Q3 		$8.04M Sell
146,968
-25,740
-15% -$1.29M 0.03% 327
2025
Q2 		$9.18M Sell
172,708
-60,489
-26% -$3.07M 0.03% 293
2025
Q1 		$10.1M Buy
233,197
+20,661
+10% +$1.05M 0.04% 262
2024
Q4 		$11.9M Sell
212,536
-45,821
-18% -$2.85M 0.04% 261
2024
Q3 		$17.6M Sell
258,357
-184,235
-42% -$10.4M 0.06% 169
2024
Q2 		$18.7M Buy
442,592
+289,852
+190% +$15.9M 0.07% 154
2024
Q1 		$10.5M Buy
152,740
+14,021
+10% +$887K 0.04% 252
2023
Q4 		$10.3M Buy
138,719
+25,103
+22% +$1.65M 0.04% 271
2023
Q3 		$7.75M Buy
113,616
+19,016
+20% +$1.61M 0.05% 292
2023
Q2 		$8.88M Sell
94,600
-15,162
-14% -$1.18M 0.05% 233
2023
Q1 		$7.44M Sell
109,762
-71,003
-39% -$4.56M 0.05% 267
2022
Q4 		$8.95M Buy
180,765
+10,281
+6% +$420K 0.07% 210
2022
Q3 		$5.54M Buy
170,484
+77,903
+84% +$3.21M 0.06% 320
2022
Q2 		$3.65M Buy
92,581
+7,367
+9% +$394K 0.03% 346
2022
Q1 		$5.96M Buy
85,214
+18,713
+28% +$1.37M 0.04% 333
2021
Q4 		$5.18M Buy
66,501
+36,431
+121% +$3.22M 0.03% 379
2021
Q3 		$2.87M Buy
30,070
+3,405
+13% +$360K 0.02% 508
2021
Q2 		$3.31M Sell
26,665
-2,913
-10% -$348K 0.02% 478
2021
Q1 		$3.9M Buy
29,578
+18,621
+170% +$2.55M 0.03% 353
2020
Q4 		$1.45M Sell
10,957
-19,063
-64% -$2.31M 0.01% 447
2020
Q3 		$3.06M Buy
30,020
+18,698
+165% +$1.61M 0.04% 286
2020
Q2 		$984K Buy
11,322
+5,837
+106% +$466K 0.01% 549
2020
Q1 		$318K Sell
5,485
-39,739
-88% -$3.23M 0.01% 419
2019
Q4 		$4.18M Sell
45,224
-15,759
-26% -$1.39M 0.06% 154
2019
Q3 		$5.51M Buy
60,983
+15,723
+35% +$1.79M 0.09% 145
2019
Q2 		$5.34M Sell
45,260
-12,830
-22% -$1.29M 0.09% 149
2019
Q1 		$5.03M Buy
+58,090
New +$4.94M 0.08% 138

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Rafferty Asset Management's EXAS Position: Q1 2026 in Review

Rafferty Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 57,455 shares — an estimated $5.84M sold.

Rafferty Asset Management first reported a position in EXAS in Q1 2019 and held it in 28 quarters. The position peaked at $18.7M in Q2 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Rafferty Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Rafferty Asset Management sold 57,455 Exact Sciences shares in Q1 2026, an estimated $5.84M.
  • Rafferty Asset Management first reported a position in Exact Sciences in Q1 2019 and held it in 28 quarters.
  • Rafferty Asset Management's Exact Sciences position peaked at $18.7M in Q2 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.